Eksakta : Berkala Ilmiah Bidang MIPA
Vol. 27 No. 05 (2026): Eksakta : Berkala Ilmiah Bidang MIPA (E-ISSN : 2549-7464) In Progress

Mechanism Activity and Spesific Chemical Compound of Purslane (Portulaca oleracea L.) in Managing Obesity: A Systematic Literature Review

Rizqi Nur Azizah (Department of Pharmacology-Toxicology, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia)
Fadlina Chany Saputri (Department of Pharmacology-Toxicology, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia)
Meidi Utami Puteri (Department of Pharmacology-Toxicology, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia)
Aktsar Roskiana Ahmad (Laboratory of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, ¬Universitas Muslim Indonesia, Makassar, Indonesia)



Article Info

Publish Date
30 Oct 2026

Abstract

Obesity is global health problem characterized by an increase in body fat, leading to adverse metabolic, biomechanical, and psychosocial health consequences. Herbal supplementation have become increasingly popular due with fewer adverse effects and lower cost Previous study showed that Portulaca oleracea L. (PO) are one of the plants that can treating obesity. This revew demonstrates that PO exhibits potential as an alternative therapeutic agent in the management of obesity through multiple pharmacological mechanisms, including reduced weight gain & body fat, improved insulin sensitivity, reduced LDL-C, triglycerides, Improved weight, BMI, liver function with multiple mechanisms that can help manage obesity, primarily through its antioxidant, anti-inflammatory, and lipid & glucose methabolism regulation. These effects are associated with the synergistic action of its bioactive constituens, including homoisoflavonoids, oleracein E and oleracein L, omega-3 Fatty Acids (ALA), quercetin, rutin, and polyphenolic compound. The dose effevtive in animal studies is between 5%-10% extract PO for 12 weeks  and 500-700 mg for 4-8 weeks in clinical trial. This eview articles suggest a need for further, advanced-phase clinical trials in humans to establish an optimal and safe dosage for long-term use.

Copyrights © 2026






Journal Info

Abbrev

eksakta

Publisher

Subject

Agriculture, Biological Sciences & Forestry Astronomy Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Energy Engineering Environmental Science Materials Science & Nanotechnology Mathematics Mechanical Engineering

Description

Eksakta : Berkala Ilmiah Bidang MIPA (E-ISSN : 2549-7464) is an open access journal and peer-reviewed that publishes either original article or reviews. The journal is dedicated towards dissemination of knowledge related to the advancement in scientific research. The prestigious interdisciplinary ...